Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lawrence Wen Jun Wong"'
Autor:
Kennedy Yao Yi Ng, Sze Huey Tan, Jack Jie En Tan, Desiree Shu Hui Tay, Ailica Wan Xin Lee, Andrea Jing Shi Ang, Lawrence Wen Jun Wong, Su Pin Choo, David Wai-Meng Tai, Joycelyn Jie Xin Lee
Publikováno v:
Liver Cancer, Pp 1-13 (2021)
Introduction: Development of immune-related adverse events (irAEs) has been associated with enhanced efficacy with the use of immune checkpoint inhibitors (ICIs). It remains unknown whether such an association exists in advanced hepatocellular carcin
Externí odkaz:
https://doaj.org/article/496d27c9aa9f4d5e9ef0778f2382933a
Autor:
Kennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, Ailica Wan Xin Lee, Desiree Shu Hui Tay, Jack Jie En Tan, Sze Huey Tan, Su Pin Choo, David Wai‐Meng Tai, Joycelyn Jie Xin Lee
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 19:312-319
Combination therapy with immune checkpoint inhibitor (ICI) and antivascular endothelial growth factor (anti-VEGF) is currently the first line treatment for advanced hepatocellular carcinoma (aHCC). However, there are many patients who may not be able
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0791ffd4d9571a3c08be542d6394736d
https://doi.org/10.1111/ajco.13837
https://doi.org/10.1111/ajco.13837
Autor:
Joycelyn Lee, Kennedy Yao Yi Ng, David Wai-Meng Tai, Andrea Jing Shi Ang, Lawrence Wen Jun Wong, Sze Huey Tan, Su Pin Choo
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 17
Introduction Immune checkpoint inhibitor (ICI) use in advanced hepatocellular carcinoma (HCC) is increasing. Real-world data on efficacy and safety, however, are lacking. Methods We conducted a retrospective review of all patients with advanced HCC s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c812390d856dbe1e4ab7cb636240e9b
https://doi.org/10.1111/ajco.13454
https://doi.org/10.1111/ajco.13454
Autor:
Sze Huey Tan, Su Pin Choo, Joycelyn Lee, Andrea Jing Shi Ang, David Wai-Meng Tai, Lawrence Wen Jun Wong, K. Ng
Publikováno v:
Annals of Oncology. 30:xi23
Background Tyrosine kinase inhibitors (TKI) are the first-line systemic treatment for patients with advanced hepatocellular carcinoma (HCC), while immune checkpoint inhibitors (ICI) were approved for use in the second-line setting in 2018. Results of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2b7c02b731fda13e8ddea0cd51a336f
https://doi.org/10.1093/annonc/mdz449.018
https://doi.org/10.1093/annonc/mdz449.018
Autor:
Lawrence Wen Jun Wong, Joycelyn Lee, K. Ng, David Wai-Meng Tai, S.H. Tan, Andrea Jing Shi Ang, S.P. Choo
Publikováno v:
Annals of Oncology. 30:ix110
Background More patients are receiving immune checkpoint inhibitors (ICI) for advanced hepatocellular carcinoma (HCC). We aim to explore whether an association exists between the presence of irAE and the efficacy of ICI in advanced HCC. Methods We co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a27bf6dbc3d4908b0372b105aeca97b0
https://doi.org/10.1093/annonc/mdz438.008
https://doi.org/10.1093/annonc/mdz438.008
Autor:
Ng, Kennedy Yao Yi1 (AUTHOR), Wong, Lawrence Wen Jun1 (AUTHOR), Ang, Andrea Jing Shi1 (AUTHOR), Lee, Ailica Wan Xin2 (AUTHOR), Tay, Desiree Shu Hui2 (AUTHOR), Tan, Jack Jie En2 (AUTHOR), Tan, Sze Huey3,4 (AUTHOR), Choo, Su Pin1,5 (AUTHOR), Tai, David Wai‐Meng1,4 (AUTHOR), Lee, Joycelyn Jie Xin1,4 (AUTHOR) joycelyn.lee.j.x@singhealth.com.sg
Publikováno v:
Asia Pacific Journal of Clinical Oncology. Jun2023, Vol. 19 Issue 3, p312-319. 8p.
Autor:
Ng, Kennedy Yao Yi1 (AUTHOR), Wong, Lawrence Wen Jun2 (AUTHOR), Ang, Andrea Jing Shi2 (AUTHOR), Tan, Sze Huey3,4 (AUTHOR), Choo, Su Pin1 (AUTHOR), Tai, David Wai‐Meng1 (AUTHOR), Lee, Joycelyn Jie Xin1 (AUTHOR) joycelyn.lee.j.x@singhealth.com.sg
Publikováno v:
Asia Pacific Journal of Clinical Oncology. Oct2021, Vol. 17 Issue 5, pe249-e261. 13p.
Autor:
Ng, Kennedy Yao Yi, Tan, Sze Huey, Tan, Jack Jie En, Tay, Desiree Shu Hui, Lee, Ailica Wan Xin, Ang, Andrea Jing Shi, Wong, Lawrence Wen Jun, Choo, Su Pin, Tai, David Wai-Meng, Lee, Joycelyn Jie Xin
Publikováno v:
Liver Cancer (2235-1795); 2022, Vol. 11 Issue 1, p9-21, 13p